Clinical Trials Logo

Cocaine Abuse clinical trials

View clinical trials related to Cocaine Abuse.

Filter by:

NCT ID: NCT00350870 Completed - Cocaine Abuse Clinical Trials

CBT With Disulfiram and Contingency Management

Start date: April 2005
Phase: Phase 1
Study type: Interventional

This is a study of four treatments for chronic cocaine use and may help study participants to control their drug use. All participants will receive weekly individual cognitive behavioral therapy (CBT).

NCT ID: NCT00350610 Completed - Cocaine Abuse Clinical Trials

Computer-Based Training in Cognitive Behavior Therapy

CBT4CBT
Start date: November 2007
Phase: Phase 1
Study type: Interventional

The computer-based training program (CBT for CBT) focuses on teaching basic coping skills, presenting examples of effective use of coping skills in a number of realistic situations in video form, and providing opportunities for patients to practice and review new skills while receiving substance abuse treatment.

NCT ID: NCT00318760 Completed - Cocaine Abuse Clinical Trials

Effect of Clonidine on Responses to Imagery Scripts

Start date: June 14, 2005
Phase: Phase 1
Study type: Interventional

Background: - Research has shown that clonidine, a drug originally prescribed to treat high blood pressure and some symptoms of opioid withdrawal, can help block stress-induced relapse to heroin and cocaine seeking in rats. However, it does not seem to block cue-induced relapse in rats. Researchers are interested in studying whether clonidine shows the same pattern of effects on stress- and cue-induced cravings for heroin or cocaine in humans. Objectives: - To compare the ability of clonidine to reduce stress- and cue-induced cocaine and heroin craving in drug abusers. Eligibility: - Individuals between 18 and 55 years of age who are current cocaine or heroin users. Design: - This study will consist of two visits: a screening visit to determine eligibility and an experimental/script session. - Before the script session, participants will provide urine and breath samples for testing. Participants will complete questionnaires to measure their current drug craving and days since last use of cocaine or heroin. - At the start of the script session, participants will receive a dose of clonidine or placebo as directed by the study researchers. Three hours after dosing, participants will be read four scripts (two neutral, one stress-inducing, and one drug-cue-related) with breaks in between each script. After each script, participants will respond to questions about levels of stress and craving. - Participants will provide saliva samples immediately before and during the script readings, and will also be measured for skin response to the scripts.

NCT ID: NCT00292123 Completed - Opioid Dependence Clinical Trials

Combined Behavioral and Pharmacologic Treatment of Polydrug Abuse

Start date: June 1999
Phase: Phase 1
Study type: Interventional

The primary goal of this study is to determine how contingency management can best be combined with standard or high doses of methadone to increase simultaneous abstinence from heroin and cocaine.

NCT ID: NCT00249457 Completed - Cocaine Dependence Clinical Trials

Employment-based Reinforcement to Motivate Drug Abstinence in the Treatment of Drug Addiction. - 2

Start date: October 1996
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether long-term exposure to the Therapeutic Workplace intervention could sustain drug abstinence over an extended period of time in heroin- and cocaine-dependent, unemployed, treatment-resistant young mothers.

NCT ID: NCT00227903 Completed - Alcohol Abuse Clinical Trials

Therapeutic Substance Abuse Treatment in Pregnancy - 1

PRIDE-P
Start date: September 2004
Phase: Phase 2
Study type: Interventional

The purpose of this study is... To assess whether a behavioral treatment that combines motivational enhancement and cognitive skills training therapy (MET-CBT) is more effective than brief advice in: 1) decreasing use of a full range of psychoactive substances (e.g. marijuana, cocaine, methamphetamines, alcohol, nicotine, opioids) in pregnant substance using and dependent women; 2) decreasing HIV risk behavior; 3) improving birth outcomes (longer gestations and greater birth weight).

NCT ID: NCT00223236 Completed - Cocaine Dependence Clinical Trials

Trial of Citicoline Therapy in Patients With Mania or Hypomania and Cocaine Abuse/Dependence

Start date: July 2010
Phase: Phase 3
Study type: Interventional

The purpose of this research is to determine if a citicoline supplement is associated with a reduction in cocaine use and craving in patients with bipolar disorder (a mental disorder marked by alternating periods of mania and depression) or schizoaffective disorder/bipolar type (a psychotic disturbance in which there is a mixture of schizophrenic and manic-depressive symptoms) and cocaine abuse/dependence. This research also wants to explore if citicoline supplements are associated with greater improvement in symptoms of mania and on memory and cognition (the mental faculty of perception, reasoning, and judgement) in these patients.

NCT ID: NCT00218257 Completed - Clinical trials for Cocaine-Related Disorders

Progesterone for the Treatment of Cocaine Dependence - 1

Start date: July 2002
Phase: N/A
Study type: Interventional

Past research has demonstrated that cocaine dependent women experience less severe responses to cocaine during the luteal phase of the menstrual cycle, when estrogen and progesterone concentrations are high. The purpose of this study is to determine whether administered progesterone reduces subjective and physiological responses to cocaine in cocaine dependent individuals.

NCT ID: NCT00218075 Completed - Clinical trials for Cocaine-Related Disorders

Behavioral Therapy Combined With Carbidopa/Levodopa for the Treatment of Cocaine Dependence

Start date: March 2000
Phase: Phase 2
Study type: Interventional

Cocaine dependence is a major public health problem; an effective primary treatment for cocaine dependent individuals has yet to be found. The purpose of this study is to examine the effectiveness of levodopa and carbidopa in treating cocaine dependent individuals. In addition, this study will examine the effects of incentive rewards for treatment compliance.

NCT ID: NCT00217997 Completed - Clinical trials for Cocaine-Related Disorders

Impulsivity, Brain Function, and Substance Abuse Treatment in Cocaine Dependent Individuals

Start date: September 2005
Phase: N/A
Study type: Observational

Cocaine dependence is a major public health problem; an effective primary treatment for cocaine dependent individuals has yet to be found. The purpose of this trial is to evaluate aspects of treatment response in cocaine dependent individuals.